Forum Πρωτοβάθμιας Φροντίδας Υγείας
ΠΦΥ -Εκπαίδευση => Αποσπάσματα από τον έντυπο & ηλεκτρονικό τύπο => Μήνυμα ξεκίνησε από: Argirios Argiriou στις 6 Μαρτίου 2018, 19:28:13
-
CLINICAL GUIDELINES |6 MARCH 2018
By the Editors
The American College of Physicians now recommends that most patients with type 2 diabetes aim for a hemoglobin A1c level between 7% and 8%. This represents a loosening of the group's 2007 recommendation, which said less than 7% was "a reasonable goal" for many patients.
In a guideline update published in the Annals of Internal Medicine, the ACP cites evidence that treating to targets of 7% or lower rather than 8% does not reduce the risk for death or macrovascular events over 5–10 years — but does result in "substantial harms," such as hypoglycemia.
In NEJM Journal Watch General Medicine, Dr. Daniel Dressler reviews the rest of the ACP's new recommendations and explains why "a more aggressive approach might be appropriate in younger patients with few comorbid conditions." Have a look at the first link below.
http://annals.org/aim/fullarticle/2674121/hemoglobin-1c-targets-glycemic-control-pharmacologic-therapy-nonpregnant-adults-type (http://annals.org/aim/fullarticle/2674121/hemoglobin-1c-targets-glycemic-control-pharmacologic-therapy-nonpregnant-adults-type)
-
Ήταν βέβαια γνωστό ήδη από το 2008:
https://www.diabetesselfmanagement.com/blog/higher-hba1c-healthier/ (https://www.diabetesselfmanagement.com/blog/higher-hba1c-healthier/)